FDA Grants CLIA Waiver to Rapid Screening Test for Syphilis
FDA’s action will permit the Syphilis Health Check test to be used by untrained healthcare workers in a variety of nontraditional settings.
Read MorePosted by Steve Halasey | Dec 30, 2014 | Compliance, Infectious Diseases, Sexually Transmitted Diseases |
FDA’s action will permit the Syphilis Health Check test to be used by untrained healthcare workers in a variety of nontraditional settings.
Read MorePosted by Steve Halasey | Dec 22, 2014 | Research |
In a study of 100 patients, test results from the Ativa point-of-care system are found to be comparable to results from larger, pricier central lab systems.
Read MorePosted by Jenny Lower | Dec 18, 2014 | Cleaners & Disinfectants, Labwear & Consumables, Uncategorized |
Featured products include the Cytation 5 cell imaging multimode readerfrom BioTek, an ebola disinfectant from Mueller Sports Medicine, and a lab coat with multiple pockets for electronic devices from ScotteVest.
Read MorePosted by Jenny Lower | Dec 15, 2014 | Sexually Transmitted Diseases |
FDA has granted CLIA-waived status to the Alere Determine HIV-1/2 Ag/Ab Combo test, making it eligible for use in physician offices and clinics. The fourth-generation test enables faster detection, within days of infection.
Read MorePosted by Steve Halasey | Dec 2, 2014 | Research |
NIH funding leads to a new, low-cost molecular diagnostic instrument, with no electricity needed.
Read More